• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Carlisle Companies Incorporated filed SEC Form 8-K: Completion of Acquisition or Disposition of Assets, Entry into a Material Definitive Agreement, Leadership Update, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Submission of Matters to a Vote of Security Holders, Regulation FD Disclosure, Financial Statements and Exhibits

    5/1/24 4:33:14 PM ET
    $CSL
    Specialty Chemicals
    Industrials
    Get the next $CSL alert in real time by email
    csl-20240501
    0000790051false--12-3100007900512024-05-012024-05-010000790051us-gaap:CommonStockMember2024-05-012024-05-01
    UNITED STATES
    SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549
    _____________________________________________________ 
     
    FORM 8-K
    _____________________________________________________ 

    CURRENT REPORT
    Pursuant to Section 13 or 15(d) of the
    Securities Exchange Act of 1934
     _____________________________________________________ 

    Date of Report (Date of earliest event reported): May 1, 2024

    carlislelogoaq12020.jpg
    www.carlisle.com 
     
    CARLISLE COMPANIES INCORPORATED
    (Exact name of registrant as specified in its charter)
    Delaware001-0927831-1168055
    (State or other jurisdiction of incorporation or organization)(Commission File Number)(I.R.S. Employer Identification No.)
     
    16430 North Scottsdale Road, Suite 400, Scottsdale, Arizona 85254
    (Address of principal executive offices, including zip code)

    480-781-5000
    (Registrant’s telephone number, including area code)
     
    Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
     
    ☐   Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
     
    ☐   Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
     
    ☐   Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
     
    ☐   Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

    Securities registered pursuant to Section 12(b) of the Act:
    Title of each classTrading Symbol(s)Name of exchange on which registered
    Common stock, $1 par valueCSLNew York Stock Exchange

    Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

    ☐    Emerging growth company

    ☐    If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.


    Item 2.01.    Completion of Acquisition or Disposition of Assets.
    On May 1, 2024, Carlisle Companies Incorporated (the "Company") completed the transaction contemplated by the Unit Purchase Agreement, dated as of March 18, 2024 (the "Purchase Agreement"), with PWP Growth Equity Fund II LP, MTL CP LP, MTL Management Pool LLC, PWP Growth Equity Fund II B LP, Newbury Equity Partners V L.P., HQ Capital SCS SICAV-SIF — Auda Co-Investment Fund II, Regent Street Co-Investment Fund 2018-5, LLC, Trinity Alps Private Opportunities Fund I B LLC, Antares Capital 2 LP, Randolph Street Ventures, L.P., Jeffrey C. Walker and Chavkin Management Corp (collectively, the "Sellers"), MTL Holdings LLC ("MTL Holdings"), MTL GEF Blocker LLC ("Blocker") and, solely in its capacity as the representative of all of the Sellers, PWP Growth Equity Fund II LP.
    Pursuant to the Purchase Agreement, the Company acquired all of the equity interests of MTL Holdings and Blocker in exchange for cash consideration in the amount of $410 million, subject to certain customary purchase price adjustments.
    The material terms of the Purchase Agreement were previously reported in Item 1.01 of the Company's Current Report on Form 8-K filed on March 20, 2024 with the U.S. Securities and Exchange Commission (the "SEC").
    Item 5.02.    Departure of Directors or Certain Officers; Election of Directors; Appointments of Certain Officers; Compensatory Arrangements of Certain Officers.
    On May 1, 2024, the Company held its 2024 annual meeting of stockholders (the “Annual Meeting”). At the Annual Meeting, the Company’s stockholders approved an amendment and restatement of the Company’s Incentive Compensation Program (the “2024 Incentive Compensation Program”), which had been previously approved by the Company’s Board of Directors (the “Board”) subject to stockholder approval, to: (i) increase the total number of shares of the Company’s common stock (“Shares”) available for issuance by an additional 1,400,000 Shares such that a total of 2,770,039 Shares will be available for issuance under the 2024 Incentive Compensation Program; (ii) increase the number of those Shares that will be available for grant as restricted Shares, performance Shares or other “full value” awards by an additional 276,169 Shares such that a total of 850,000 Shares will be available for issuance as restricted Shares, performance Shares or other “full value” awards; (iii) extend the term of the 2024 Incentive Compensation Program through December 31, 2033; (iv) add a $500,000 cap on total annual compensation payable to non-employee directors under the 2024 Incentive Compensation Program; and (v) make other changes to the 2024 Incentive Compensation Program in response to recent regulatory developments and to address and clarify certain administrative matters. The 2024 Incentive Compensation Program is more fully described under “Proposal 4: Approval of the Company’s Amended and Restated Incentive Compensation Program” in the Company’s definitive proxy statement on Schedule 14A filed with the SEC on March 19, 2024 (the “Proxy Statement”), and this description is incorporated by reference in this Current Report on Form 8-K (this “Report”). A copy of the 2024 Incentive Compensation Program is attached as Exhibit 10.1 to this Report and is incorporated herein by this reference.
    Item 5.03.    Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year.
    At the Annual Meeting, the Company’s stockholders adopted amendments to the Company’s Amended and Restated Certificate of Incorporation (the “Charter”) to: (i) remove the advance notice requirements for director nominations (the “Advance Notice Charter Amendment”) and move them to the Company’s Amended and Restated Bylaws (the “Bylaws”); and (ii) reflect recent Delaware law changes regarding officer exculpation (the “Officer Exculpation Charter Amendment” and, together with the Advance Notice Charter Amendment, the “Charter Amendments”). The Advance Notice Charter Amendment is more fully described under “Proposal 2: Adoption of Amendment to the Company’s Charter to Remove the Advance Notice Requirements for Director Nominations and Move Them to the Company’s Bylaws” in the Proxy Statement, and this description is incorporated by reference in this Report. The Officer Exculpation Charter Amendment is more fully described under “Proposal 3: Adoption of Amendment to the Company’s Charter to Reflect Recent Delaware Law Changes Regarding Officer Exculpation” in the Proxy Statement, and this description is incorporated by reference in this Report. The Charter Amendments were effective upon the filing of the Company’s Amended and Restated Certificate of Incorporation that includes the Charter Amendments (as amended, the “Amended and Restated Charter”) with the Secretary of State of the State of Delaware on May 1, 2024. A copy of the Amended and Restated Charter is attached as Exhibit 3.1 to this Report and is incorporated herein by this reference.
    On May 1, 2024, the Board approved amendments to the Company’s Bylaws (as amended, the “Amended and Restated Bylaws”) to: (i) move the advance notice requirements for the Company’s stockholders to nominate persons for election to the Board at an annual or special meeting of stockholders (the “Advance Notice Requirements”) from the Charter to the Bylaws; and (ii) update the Advance Notice Requirements to address the



    SEC’s universal proxy rule in Rule 14a-19 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), and incorporate proxy access procedures, as more fully set forth in Sections 1.08 and 1.09, respectively, of the Amended and Restated Bylaws attached as Appendix B to the Proxy Statement. The Amended and Restated Bylaws became effective immediately upon the effectiveness of the Charter Amendments. A copy of the Amended and Restated Bylaws is attached as Exhibit 3.2 to this Report and is incorporated herein by this reference.
    Item 5.07.    Submission of Matters to a Vote of Security Holders.
    At the Annual Meeting, the Company’s stockholders: (i) elected all three of the directors nominated by the Board; (ii) adopted the Advance Notice Charter Amendment; (iii) adopted the Officer Exculpation Charter Amendment; (iv) approved the 2024 Incentive Compensation Program; (v) approved, on an advisory basis, the compensation of the Company’s named executive officers for 2023 as disclosed in the Proxy Statement; and (iv) ratified the appointment of Deloitte & Touche LLP to serve as the Company’s independent registered public accounting firm for the year ending December 31, 2024. Each of these proposals is further described in the Proxy Statement. Final voting results on each proposal submitted to the Company’s stockholders at the Annual Meeting are as follows:
    Proposal 1. Election of Directors:
    Director
    Votes For
    Votes Against
    Abstentions
    Broker
    Non-Votes
    James D. Frias
    39,793,9471,819,63629,4572,496,590
    Maia A. Hansen
    33,364,4718,166,214112,3552,496,590
    Corrine D. Ricard
    40,018,6861,593,89330,4612,496,590
    Proposal 2. Adoption of the Advance Notice Charter Amendment:
    Votes For
    Votes Against
    Abstentions
    Broker
    Non-Votes
    41,452,330127,43363,2772,496,590
    Proposal 3. Adoption of the Officer Exculpation Charter Amendment:
    Votes For
    Votes Against
    Abstentions
    Broker
    Non-Votes
    33,631,5377,943,97367,5302,496,590
    Proposal 4. Approval of the 2024 Incentive Compensation Program:
    Votes For
    Votes Against
    Abstentions
    Broker
    Non-Votes
    40,028,7361,560,19054,1142,496,590
    Proposal 5. Approval, on an advisory basis, of the compensation of the Company’s named executive officers for 2023:
    Votes For
    Votes Against
    Abstentions
    Broker
    Non-Votes
    36,594,4374,919,005129,5982,496,590
    Proposal 6. Ratification of Deloitte & Touche LLP:
    Votes For
    Votes Against
    Abstentions
    44,039,32875,37324,929
    Item 7.01.    Regulation FD Disclosure.
    On May 1, 2024, the Company issued a press release announcing the closing of the transaction contemplated by the Purchase Agreement. A copy of the press release is furnished as Exhibit 99.1 to this Report.
    The information in this Item 7.01 of this Report, including Exhibit 99.1, is being furnished herewith and shall not be deemed "filed" for the purposes of Section 18 of the Exchange Act or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference into any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as expressly set forth by specific reference in such filing.



    Item 9.01.    Financial Statements and Exhibits.
    (d)          Exhibits  
    Exhibit NumberExhibit Title
    2.1*
    Unit Purchase Agreement, dated as of March 18, 2024, by and between Carlisle Companies Incorporated Carlisle Companies Incorporated, PWP Growth Equity Fund II LP, MTL CP LP, MTL Management Pool LLC, PWP Growth Equity Fund II B LP, Newbury Equity Partners V L.P., HQ Capital SCS SICAV-SIF – Auda Co-Investment Fund II, Regent Street Co-Investment Fund 2018-5, LLC, Trinity Alps Private Opportunities Fund I B LLC, Antares Capital 2 LP, Randolph Street Ventures, L.P., Jeffrey C. Walker, Chavkin Management Corp, MTL Holdings LLC, MTL GEF Blocker LLC, and, solely in its capacity as the sellers’ representative, PWP Growth Equity Fund II LP (incorporated by reference to Exhibit 2.1 to Carlisle Companies Incorporated’s Current Report on Form 8-K filed March 20, 2024 (File No. 001-09278)).
    3.1
    Amended and Restated Certificate of Incorporation of Carlisle Companies Incorporated.
    3.2
    Amended and Restated Bylaws of Carlisle Companies Incorporated.
    10.1**
    Carlisle Companies Incorporated Incentive Compensation Program, as amended and restated effective January 1, 2024.
    99.1
    Press release of Carlisle Companies Incorporated, dated May 1, 2024.
    104Cover page interactive data file (formatted in inline XBRL).
    *
    Schedules have been omitted pursuant to Item 601(b)(2) of Regulation S-K. A copy of any omitted schedule will be furnished supplementally to the Securities and Exchange Commission upon request.
    **Management contract or compensation plan or arrangement in which directors or executive officers are eligible to participate.





    SIGNATURE
    Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
     CARLISLE COMPANIES INCORPORATED
    Date:May 1, 2024By:/s/ Kevin P. Zdimal
      Kevin P. Zdimal
      Vice President and Chief Financial Officer



    Get the next $CSL alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $CSL

    DatePrice TargetRatingAnalyst
    1/30/2026Mkt Perform
    William Blair
    10/20/2025Hold
    Vertical Research
    7/31/2025$395.00Buy → Hold
    Loop Capital
    6/24/2025$500.00Overweight
    Analyst
    11/14/2024$460.00Hold
    Truist
    4/3/2024$455.00Buy
    Goldman
    9/26/2023$325.00 → $290.00Buy → Hold
    Jefferies
    10/14/2022$363.00Neutral → Outperform
    Credit Suisse
    More analyst ratings

    $CSL
    SEC Filings

    View All

    Amendment: SEC Form SCHEDULE 13G/A filed by Carlisle Companies Incorporated

    SCHEDULE 13G/A - CARLISLE COMPANIES INC (0000790051) (Subject)

    3/26/26 4:43:09 PM ET
    $CSL
    Specialty Chemicals
    Industrials

    SEC Form DEFA14A filed by Carlisle Companies Incorporated

    DEFA14A - CARLISLE COMPANIES INC (0000790051) (Filer)

    3/17/26 6:05:30 AM ET
    $CSL
    Specialty Chemicals
    Industrials

    SEC Form DEF 14A filed by Carlisle Companies Incorporated

    DEF 14A - CARLISLE COMPANIES INC (0000790051) (Filer)

    3/17/26 6:01:20 AM ET
    $CSL
    Specialty Chemicals
    Industrials

    $CSL
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Carlisle Companies to Announce First Quarter 2026 Results on April 23, 2026

    Carlisle Companies Incorporated (NYSE:CSL) will release first quarter 2026 results on Thursday, April 23, 2026, after market close. A conference call to discuss these results has been scheduled for 5pm ET on Thursday, April 23, 2026. The call can be accessed via webcast, along with related materials, at www.carlisle.com/investors/events-and-presentations and via telephone as follows: Domestic toll free: 800-715-9871 International: 646-307-1963 Conference ID: 7254110 Please dial in or access the webcast at least 10 minutes prior to the start of the call. An audio replay will be available on the Company's website shortly after the completion of the call. About Carlisle Companies Incorpo

    4/9/26 4:05:00 PM ET
    $CSL
    Specialty Chemicals
    Industrials

    Carlisle Companies Publishes 2025 Annual Report

    Carlisle Companies Incorporated (NYSE:CSL) today published its 2025 Annual Report, highlighting resilient financial performance, continued execution of Vision 2030, and significant progress in building a scalable, enterprise-wide innovation engine. "2025 marked a year of meaningful progress against our Vision 2030 strategy along with solid results in a challenging environment," said Chris Koch, Chair, President and Chief Executive Officer. "We delivered $5.0 billion in revenue, $19.40 in adjusted EPS, and a 24.4% adjusted EBITDA margin, while continuing to invest in innovation, strategic acquisitions, and disciplined capital allocation to drive long-term value creation." Koch added, "In

    3/25/26 9:25:00 AM ET
    $CSL
    Specialty Chemicals
    Industrials

    Carlisle Companies Reports Fourth Quarter Results

    Carlisle Companies Incorporated (NYSE:CSL) today announced its fourth quarter 2025 financial results. Fourth quarter revenue of $1.1 billion, up 0.4% year-over-year Fourth quarter diluted EPS of $3.19 and adj. EPS of $3.90 Generated $1.1 billion in operating cash flow in 2025 Repurchased $300 million of shares in Q4, totaling $1.3 billion of share repurchases in 2025 2026 outlook includes LSD revenue growth and ~50 bps of adj. EBITDA margin expansion Comments from Chris Koch, Chair, President and Chief Executive Officer "Throughout 2025, despite continued headwinds in new construction and a complex economic environment, we continued to execute against our Vision 2030 str

    2/3/26 4:05:00 PM ET
    $CSL
    Specialty Chemicals
    Industrials

    $CSL
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 4 filed by Director Palmer Sheryl

    4 - CARLISLE COMPANIES INC (0000790051) (Issuer)

    3/2/26 6:28:54 PM ET
    $CSL
    Specialty Chemicals
    Industrials

    SEC Form 4 filed by Director Collins Jonathan R.

    4 - CARLISLE COMPANIES INC (0000790051) (Issuer)

    3/2/26 6:21:48 PM ET
    $CSL
    Specialty Chemicals
    Industrials

    SEC Form 4 filed by Director Frias James D

    4 - CARLISLE COMPANIES INC (0000790051) (Issuer)

    3/2/26 6:19:53 PM ET
    $CSL
    Specialty Chemicals
    Industrials

    $CSL
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    William Blair initiated coverage on Carlisle Cos

    William Blair initiated coverage of Carlisle Cos with a rating of Mkt Perform

    1/30/26 6:58:54 AM ET
    $CSL
    Specialty Chemicals
    Industrials

    Vertical Research initiated coverage on Carlisle Cos

    Vertical Research initiated coverage of Carlisle Cos with a rating of Hold

    10/20/25 3:33:33 PM ET
    $CSL
    Specialty Chemicals
    Industrials

    Carlisle Cos downgraded by Loop Capital with a new price target

    Loop Capital downgraded Carlisle Cos from Buy to Hold and set a new price target of $395.00

    7/31/25 7:57:21 AM ET
    $CSL
    Specialty Chemicals
    Industrials

    $CSL
    Leadership Updates

    Live Leadership Updates

    View All

    Carlisle Companies Announces Leadership Appointments

    Carlisle Companies Incorporated (NYSE:CSL) is pleased to announce that, effective November 3, 2025, Jason Taylor will join the company as President of its Construction Materials business (CCM). As part of this transition, Steve Schwar will assume the role of Vice Chair of CCM to ensure a smooth and effective leadership transition. Both Mr. Taylor and Mr. Schwar will report to Chris Koch, Carlisle's Chair, President, and Chief Executive Officer. Mr. Taylor has joined CCM after more than 14 years at Beacon Building Products, now known as QXO, Inc., a leading distributor of roofing and complementary building products. At Beacon, Mr. Taylor held several key leadership roles, including most re

    11/3/25 9:00:00 AM ET
    $CSL
    Specialty Chemicals
    Industrials

    Carlisle Companies Announces Leadership Appointments

    Carlisle Companies Incorporated (NYSE:CSL) today announced the appointment of Christopher B. Gaskill as Vice President & General Counsel for the Company. In conjunction with this appointment, Scott C. Selbach will transition to a new role as Executive Vice President, Government Relations for the Company. Mr. Selbach will also remain Secretary of the Company. Both Mr. Gaskill and Mr. Selbach will report to Chris Koch, Carlisle's Chair, President & Chief Executive Officer. Prior to joining Carlisle, Mr. Gaskill served as Executive Vice President, Chief Legal Officer, and Secretary at Summit Materials, Inc. (NYSE:SUM), where he was responsible for the company's global legal functions and ensu

    5/16/25 4:05:00 PM ET
    $CAH
    $CSL
    $SUM
    Other Pharmaceuticals
    Health Care
    Specialty Chemicals
    Industrials

    The Riverside Company Signs Definitive Agreement to Sell Its PFB Insulation Products Business to Carlisle Companies

    CLEVELAND, Oct. 21, 2024 (GLOBE NEWSWIRE) -- The Riverside Company, a global investment firm focused on the smaller end of the middle market, together with its portfolio company PFB Corporation (PFB), is pleased to announce the firm has signed a definitive agreement to sell PFB's Plasti-Fab and Insulspan business units to Carlisle Companies Incorporated (NYSE:CSL). The sale price for the business is approximately USD $260 million, and the transaction is expected to close in Q4 2024. Headquartered in Calgary, Alberta, PFB is a leading vertically integrated provider of Expanded Polystyrene (EPS)-based insulation products throughout North America. PFB's Plasti-Fab division operates eight man

    10/21/24 12:30:05 PM ET
    $CSL
    Specialty Chemicals
    Industrials

    $CSL
    Financials

    Live finance-specific insights

    View All

    Carlisle Companies to Announce First Quarter 2026 Results on April 23, 2026

    Carlisle Companies Incorporated (NYSE:CSL) will release first quarter 2026 results on Thursday, April 23, 2026, after market close. A conference call to discuss these results has been scheduled for 5pm ET on Thursday, April 23, 2026. The call can be accessed via webcast, along with related materials, at www.carlisle.com/investors/events-and-presentations and via telephone as follows: Domestic toll free: 800-715-9871 International: 646-307-1963 Conference ID: 7254110 Please dial in or access the webcast at least 10 minutes prior to the start of the call. An audio replay will be available on the Company's website shortly after the completion of the call. About Carlisle Companies Incorpo

    4/9/26 4:05:00 PM ET
    $CSL
    Specialty Chemicals
    Industrials

    Carlisle Companies Publishes 2025 Annual Report

    Carlisle Companies Incorporated (NYSE:CSL) today published its 2025 Annual Report, highlighting resilient financial performance, continued execution of Vision 2030, and significant progress in building a scalable, enterprise-wide innovation engine. "2025 marked a year of meaningful progress against our Vision 2030 strategy along with solid results in a challenging environment," said Chris Koch, Chair, President and Chief Executive Officer. "We delivered $5.0 billion in revenue, $19.40 in adjusted EPS, and a 24.4% adjusted EBITDA margin, while continuing to invest in innovation, strategic acquisitions, and disciplined capital allocation to drive long-term value creation." Koch added, "In

    3/25/26 9:25:00 AM ET
    $CSL
    Specialty Chemicals
    Industrials

    Carlisle Companies Reports Fourth Quarter Results

    Carlisle Companies Incorporated (NYSE:CSL) today announced its fourth quarter 2025 financial results. Fourth quarter revenue of $1.1 billion, up 0.4% year-over-year Fourth quarter diluted EPS of $3.19 and adj. EPS of $3.90 Generated $1.1 billion in operating cash flow in 2025 Repurchased $300 million of shares in Q4, totaling $1.3 billion of share repurchases in 2025 2026 outlook includes LSD revenue growth and ~50 bps of adj. EBITDA margin expansion Comments from Chris Koch, Chair, President and Chief Executive Officer "Throughout 2025, despite continued headwinds in new construction and a complex economic environment, we continued to execute against our Vision 2030 str

    2/3/26 4:05:00 PM ET
    $CSL
    Specialty Chemicals
    Industrials

    $CSL
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G/A filed by Carlisle Companies Incorporated (Amendment)

    SC 13G/A - CARLISLE COMPANIES INC (0000790051) (Subject)

    2/13/24 5:00:59 PM ET
    $CSL
    Specialty Chemicals
    Industrials

    SEC Form SC 13G/A filed by Carlisle Companies Incorporated (Amendment)

    SC 13G/A - CARLISLE COMPANIES INC (0000790051) (Subject)

    2/9/23 11:12:44 AM ET
    $CSL
    Specialty Chemicals
    Industrials

    SEC Form SC 13G/A filed by Carlisle Companies Incorporated (Amendment)

    SC 13G/A - CARLISLE COMPANIES INC (0000790051) (Subject)

    1/12/23 8:25:42 AM ET
    $CSL
    Specialty Chemicals
    Industrials